Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs

Saxenda vs Mounjaro

Editorial comparison of Saxenda (liraglutide) and Mounjaro (tirzepatide). Same drug class context, trial-anchored data, no marketing claims.

Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.

Side-by-side

DimensionSaxendaMounjaro
Generic nameliraglutidetirzepatide
ManufacturerNovo NordiskEli Lilly
FDA approved20142022
MechanismSingle GLP-1 receptor agonist. Same mechanism family as semaglutide/Wegovy but shorter half-life (~13 hours) requiring daily dosing instead of weekly.Same as Zepbound — dual GLP-1/GIP receptor agonist. Strong glycemic effect plus weight loss.
DosingTitrated weekly: 0.6mg → 1.2mg → 1.8mg → 2.4mg → 3.0mg maintenance, all once daily.Titrated 2.5mg → 15mg weekly over months, same schedule as Zepbound.
CostList price ~$1,350/month. Cash-pay similar. Insurance coverage variable. Cheaper coupons through Novo Nordisk savings card programs.Similar to Zepbound — list ~$1,000/month, LillyDirect Self-Pay $399-549/month.
Pivotal trial result8.4% mean body-weight reduction at 56 weeks (3.0 mg dose)2.0–2.3% HbA1c reduction across SURPASS trials (15 mg dose)

Full Saxenda review →

FDA-approved daily injectable liraglutide for chronic weight management. Older-generation GLP-1, daily dosing.

Full Mounjaro review →

FDA-approved tirzepatide for type 2 diabetes. Off-label for weight loss is common.

Frequently asked

Is Saxenda or Mounjaro more effective?+

In their pivotal trials, Saxenda reported 8.4% mean body-weight reduction at 56 weeks (3.0 mg dose), while Mounjaro reported 2.0–2.3% HbA1c reduction across SURPASS trials (15 mg dose). Head-to-head results vary by patient profile, dose tolerated, and adherence — these trial numbers describe averages, not what every individual experiences.

How do Saxenda and Mounjaro compare on cost?+

Saxenda: List price ~$1,350/month. Cash-pay similar. Insurance coverage variable. Cheaper coupons through Novo Nordisk savings card programs. Mounjaro: Similar to Zepbound — list ~$1,000/month, LillyDirect Self-Pay $399-549/month. Real out-of-pocket depends on insurance formulary tier, manufacturer savings programs, and whether a direct-pay channel is available.

Can I switch from Saxenda to Mounjaro?+

Switching between brand-name treatments in the same drug class is common, but the conversion is not always 1:1. Discuss the switch with your prescriber — they'll usually re-titrate dosing rather than substitute equivalent strengths directly.

Are Saxenda and Mounjaro the same drug?+

No. Saxenda (liraglutide) and Mounjaro (tirzepatide) are distinct medications from Novo Nordisk and Eli Lilly respectively. They may share a drug class or mechanism but differ in active ingredient, dosing, and approved use.

We may earn a commission when you click links to partners. Affiliate disclosure.